£414K
The Greater Manchester spinout secured the capital from backers including The North West Fund for Biomedical and Central Manchester Foundation Trust to fund pre-clinical trials.
Gelexir Healthcare
Gelexir Healthcare creates an injectable hydrogel to treat chronic back pain.
£414KTotal raised
A University of Manchester spinout that has developed an injectable hydrogel designed to relieve back pain and potentially replace invasive surgery.